Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
06/2005
06/07/2005US6903122 Crystals of benzimidazole compounds
06/07/2005US6903119 (2R)-N-(1-benzylpiperidin-4-yl)-3-cyclohexylmethylthio-2-((4R) -3-(pyridin-3-ylcarbonyl)thiazolidin-4-ylcarbonylamino)propana mide, calcium channel blocker, treatment of cerebral infarct, transient ischemic attack, spinal angiopathy
06/07/2005US6903118 Piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides
06/07/2005US6903117 Indole derivatives for the treatment of osteoporosis
06/07/2005US6903115 Bipiperidine compounds
06/07/2005US6903112 Nitrogen compounds such as 1-benzenesulfonyl-3-piperidin-3-yl -1H-indole, used as serotonin receptor antagonists, for prophylaxis of nervous system disorders
06/07/2005US6903109 Arylindenopyridines and related therapeutic and prophylactic methods
06/07/2005US6903107 Serine protease inhibitor
06/07/2005US6903104 Antitumor agents, anticarcinogenic agents, a 3-oxoacetamideindolyl compounds, for treating cancer, cytotoxic, and angiogensis inhibitors
06/07/2005US6903103 Linear cyclic ureas
06/07/2005US6903102 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
06/07/2005US6903101 Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity
06/07/2005US6903098 Use of phthalazine derivatives
06/07/2005US6903096 Quinazoline derivatives as medicaments
06/07/2005US6903095 Phthalimido derivatives and a process for their preparation
06/07/2005US6903094 As analgesic
06/07/2005US6903091 Kidney diseases; hypotensive agents; blood disorders
06/07/2005US6903088 Compounds which inhibit leukocyte adhesion mediated by VLA-4
06/07/2005US6903085 Substituted piperidine compounds useful as modulators of chemokine receptor activity
06/07/2005US6903079 Nucleoside compounds and compositions thereof
06/07/2005CA2299036C 4-phenyl-4-heteroarylpiperidine derivatives
06/07/2005CA2225439C Propiophenone derivatives and process for preparing the same
06/07/2005CA2186039C New oral pharmaceutical dosage form
06/02/2005WO2005051046A1 Light-emitting device, organic compound and display
06/02/2005WO2005049608A1 Quinolonecarboxylic acid compounds having 5-ht4 receptor agonistic activity
06/02/2005WO2005049606A1 Heteroaryl derivatives as ppar activators
06/02/2005WO2005049604A2 Antithrombotic aromatic ethers
06/02/2005WO2005049603A1 Pyrrol derivatives
06/02/2005WO2005049602A1 Quinolone antibacterial agents
06/02/2005WO2005049601A1 Indazol-3-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (vr1)
06/02/2005WO2005049600A1 Beta-lactams for treatment of cns disorders
06/02/2005WO2005049594A1 N-acylsulfonamide apoptosis promoters
06/02/2005WO2005049593A2 N-acylsulfonamide apoptosis promoters
06/02/2005WO2005049589A2 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases
06/02/2005WO2005049581A1 Pyridazin-3 (2h) -one derivatives and their use as pde4 inhibitors
06/02/2005WO2005049579A2 Immobilized n-substituted tricyclic 3-aminopyrazoles for the identification of biomolecular targets
06/02/2005WO2005049578A1 Substituted pyrazoles as ppar agonists
06/02/2005WO2005049577A1 1-amino-isoquinoline derivatives for the treatment of diseases associated with inappropriate alk5
06/02/2005WO2005049564A1 Amide derivatives and methods of their use
06/02/2005WO2005049559A2 Novel piperidine-substituted indoles- or hetero-derivatives thereof and their use as modulators of chemokine receptor (ccr-3)
06/02/2005WO2005049033A1 Pyrazole derivatives as inhibitors of receptor tyrosyne kinases
06/02/2005WO2005049019A1 N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
06/02/2005WO2005048922A2 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors
06/02/2005WO2005035528A3 Triazole derivatives as antibacterial agents
06/02/2005WO2005027823A3 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (gsk-3)
06/02/2005WO2005023794A3 Compound libraries of 4-carboxamidopiperidine derivatives
06/02/2005WO2005016879A3 Cyclic pyrazinoylguanidine sodium channel blockers
06/02/2005WO2005005380A3 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
06/02/2005WO2004063150A3 Diagnostic and therapeutic alkyl piperidine/piperazine compounds and process
06/02/2005WO2004011456A9 Protein tyrosine kinase inhibitors
06/02/2005US20050119489 Antidiabetic, anorexigenic, hypotensive, and anticholesterol agents that are synergistically combined with other active agents; obesity, premenstrual tension, hyperlipidemia, myocardial infarction and skin disorders
06/02/2005US20050119486 Diamine derivatives
06/02/2005US20050119484 Mitotic kinesin inhibitors
06/02/2005US20050119329 Tetronic and tetramic acids
06/02/2005US20050119308 Remedy for sleep disturbance
06/02/2005US20050119290 N-(2-[N',N'-diethylamino]-5-[N''-(4-fluorophenylsulfonyl)-N''-propargylamino]pyrimidin-4-yl)-4'-(pyrrolidin-1-ylcarbonyloxy)-L-phenylalanine; antiinflammatory, antiarthritic agents
06/02/2005US20050119274 3-[5-chloro-6-methyl-2-(4-methyl-piperazin-1-yl)-pyrimidin-4-yl]-4-( 1H-indol-3-yl)-pyrrole-2,5-dione; T lymphocytes, Protein Kinase C (PKC) and glycogen synthase kinase 3 beta (GSK3B) mediated diseases;
06/02/2005US20050119271 Pyrimidine A2B selective antagonist compounds, their synthesis and use
06/02/2005US20050119269 Heterocyclic compounds and methods of making and using thereof
06/02/2005US20050119268 Treatment of CRTH2-mediated diseases and conditions
06/02/2005US20050119266 Pyrrolidine and piperidine derivatives as factor Xa inhibitors
06/02/2005US20050119256 Aromatic amino acid derivates and medicinal compositions
06/02/2005US20050119252 Ligands of melanocortin receptors and compositions and methods related thereto
06/02/2005US20050119250 Amino-derivatives as novel inhibitors of histone deacetylase
06/02/2005US20050119246 2-(4-{[1-(2,2-dimethylpropanoyl)-4-piperidinyl]methyl}-3,5-dimethyl-1H-pyrazol-1-yl)-1-methylethylcarbamate; appetite suppressants; obesity, diabetes, feeding behavior, bulimia, anorexia nervosa and premenstrual tension; side effect reduction
06/02/2005US20050119234 Cannabimimetic indole derivatives
06/02/2005US20050119227 Cyclic amine bace-1 inhibitors having a benzamide substituent
06/02/2005US20050119225 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs
06/02/2005US20050119168 Macrocyclic inhibitors of hepatitis C virus NS3-serine protease
06/02/2005US20050118619 Dark quenchers for fluorescence resonance energy transfer (FRET) in bioassays
06/02/2005US20050116627 Electrochromic salts, solutions, and devices
06/02/2005DE10354060A1 Pyrrolderivate Pyrrole
06/02/2005DE10335545A1 New bicyclic nitrogen-containing heteroaryl-substituted amides, are inhibitors of Factor Xa and/or related serine proteases, useful as antithrombotic agents, e.g. for treating or preventing deep leg vein thrombosis
06/02/2005DE10123573B4 N-Oxidanthranylamid-Derivate und deren Verwendung als Arzneimittel N-Oxidanthranylamid derivatives and their use as medicaments
06/02/2005CA2546007A1 Beta-lactams for treatment of cns disorders
06/02/2005CA2545710A1 Indazol-3-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (vr1)
06/02/2005CA2545261A1 Piperidine-substituted indoles- or heteroderivatives thereof
06/02/2005CA2545193A1 Pyridazin-3 (2h) -one derivatives and their use as pde4 inhibitors
06/02/2005CA2543239A1 Heteroaryl derivatives as ppar activators
06/01/2005EP1535912A1 Muscarinic agonists
06/01/2005EP1535909A2 Cyclic amine derivatives and their use as drugs
06/01/2005EP1535906A1 Nitrogen-containing compounds
06/01/2005EP1535905A1 Process for the preparation of paraphenylendiamines comprising pyrrolidines substituted by nitrogenradicals and their intermediates
06/01/2005EP1534703A2 Antagonists of melanin concentrating hormone receptor
06/01/2005EP1534702A1 Two-photon absorption heteroaromatic chromophores and compositions thereof
06/01/2005EP1534701A1 Substituted heterocyclylpyrimidines
06/01/2005EP1534695A2 Tyrosine kinase inhibitors
06/01/2005EP1534693A2 1, 3-diamino-2-hydroxypropane prodrug derivatives
06/01/2005EP1534689A1 Novel carboxamide compounds having an mch-antagonistic effect, medicaments containing said compounds, and methods for the production thereof
06/01/2005EP1534687A1 Pyrimidine compounds
06/01/2005EP1534686A2 Nf-kb inhibitors and uses thereof
06/01/2005EP1534685A1 1h-indazole-3-carboxamide compounds as cyclin dependent kinases (cdk) inhibitors
06/01/2005EP1534683A2 Cyclooxygenase-2 selective inhibitors, compositions and methods of use
06/01/2005EP1534681A1 Substituted quinoline ccr5 receptor antagonists
06/01/2005EP1534680A1 Prenylation inhibitors and methods of their synthesis and use
06/01/2005EP1534679A2 Inhibitors of post-amadori advanced glycation end products
06/01/2005EP1534678A1 Pleuromutilin derivatives as antimicrobbials
06/01/2005EP1534676A1 Piperidinetriol derivatives as inhibitors of glycosylceramide synthase
06/01/2005EP1534296A1 Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
06/01/2005EP1534282A2 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases
1 ... 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 ... 1080